Additional studies will be needed to assess the effects of CPCs with HO-1 gain-of-function in vivo in a mouse model of myocardial infarction, in which extended retention after implantation of CPCs into the myocardium will be investigated. The gene discussed is HMOX1; the disease is myocardial infarction.